Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

4 results about "Haemolysis" patented technology

Destruction of red blood cells

Automatic sampler provided with dilution tank and dilution pipeline

PendingJP2025068291AComponent separationHaemolysisAutosampler
To provide an automatic sampler for a liquid chromatography provided with a dilution tank and a dilution pipeline which enhance haemolysis / dilution efficiency in a compact and inexpensive manner.SOLUTION: An automatic sampler for a liquid chromatography is provided with an automatic sampler part which contains an aspirator and an ejector for a biological specimen of an analysis object and cleaning fluid, and a dilution unit. The dilution unit is provided with a dilution block containing a dilution tank, a pump which sucks and discharges a blend of the biological specimen of the analysis object and the cleaning fluid, and a dilution device which fluidly connects the dilution tank and the pump.SELECTED DRAWING: Figure 1
Owner:TOSOH CORP

Sensing an analyte and assessing a hemolysis level in blood

A sensor for sensing analytes in blood comprising plasma and erythrocytes, the sensor comprising: an analyte sensor configured to sense an analyte in the blood and to output a response corresponding to the sensed analyte; and a separation device adapted to mutually separate the plasma and the erythrocytes, for assessing a haemolysis level of the blood based on a colour and / or a fluorescence of the separated plasma.
Owner:KALIUM HEALTH LTD

Methods and compositions for treatment of preeclampsia and cancer

Provided herein, in various embodiments, are compounds of general formula I:for use in the treatment of preeclampsia and preeclampsia associated conditions eclampsia, haemorrhagic stroke, haemolysis, elevated liver enzymes and low platelet count (HELLP) syndrome, placental abruption, renal failure and pulmonary oedema. Also described in embodiments herein are compounds of general formula IIor general formula IIIfor use in the prevention of cancer.
Owner:AKKADIAN THERAPEUTICS INC

Diagnosis of haemolysis

PCT designated stageWO2026093607A1Disease diagnosisBiological testingHaemolysisBiomedical engineering
The invention provides methods for determining the presence or absence of haemolysis in a subject, as well as devices suitable for use in these methods.
Owner:OXFORD UNIVERSITY INNOVATION LTD